Cover Image
Market Research Report

Over-the-Counter (OTC) Drugs Market Size By Product, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025

Published by Global Market Insights Inc. Product code 820591
Published Content info 128 Pages
Delivery time: 2-3 business days
Price
Back to Top
Over-the-Counter (OTC) Drugs Market Size By Product, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025
Published: February 14, 2019 Content info: 128 Pages
Description

Title:
Over-the-Counter (OTC) Drugs Market Size By Product (Analgesics, Cold, Cough & Flu Products, Weight Loss Products, Gastrointestinal Products, Skin Products, Mineral and Vitamin Supplements, Sleeping Aids, Ophthalmic Products), Industry Analysis Report, Regional Outlook U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Poland, China, India, Japan, Australia, South Korea, Taiwan, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Qatar, Kuwait), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025.

Over-the-Counter (OTC) Drugs Market will reach over USD 185 billion by 2025; as per a new research report.

Growing elderly population base, highly prone to suffer from several ailments such as joint pain will drive the demand of OTC drugs. Rising awareness about numerous diseases and accessibility of non-prescription for the same will continue to aid self-medication trend during the projection years. Expanding shift by pharmaceutical companies from Rx to OTC owing to favorable regulations will drive market growth. Moreover, increasing patent expiration will further motivate pharmaceutical companies to switch from Rx to OTC.

Growing trend of self-medication in developing economies and increasing dependency on internet to gain more information will further provoke self-treatment tendency among people over the forecast period.

Over-the-counter market growth is likely to be hindered by concerns pertaining to substance abuse and incorrect diagnosis. Moreover, drug abuse leading to various health problems such as heart problems, memory loss, kidney failure should impede market growth during the forecast timeline.

Minerals and vitamins business dominated the industry in 2018 by accounting for over 28.5% of market share, owing to increasing trends towards using vitamins and minerals for improved health. Easy access to multivitamins and minerals, along with increasing usage of vitamin D will propel the business size during the forecast timeframe.

Across the globe, ophthalmic OTC drugs market will witness 6.0% CAGR in future because of demand arising from growing needs of elderly population vulnerable to eye related diseases.

U.S. over-the-counter drugs market recorded to be the largest in 2016 and will grow at substantial rate owing to presence of huge geriatric patient pool, rising number of people suffering from chronic diseases associated pains and growing obesity among individuals.

Germany over-the-counter drugs market held over 18% market share of European industry in 2018 due to intensifying push towards licensing of over-the-counter medicines for treating chronic conditions. Also, increasing measures to improve health, wellbeing, fitness and willingness to invest in self-medication will augment industry growth.

Large baby boomer's population, escalating awareness and self-medication trend will support growth of the otherwise descending Japanese OTC drugs market during the projection years.

Growing demand for non-prescription drugs and high life expectancy coupled with healthcare infrastructure advancements will drive Australian market during the forecast period.

Some of the notable industry players are Bayer Corporation, GlaxoSmithKline, Sanofi, Johnson & Johnson, Pfizer, Sun Pharmaceutical Industries, Novartis, Cipla, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories and Glenmark Pharmaceuticals.

Major industry players are increasing their focus on research activities for new product development. They are also emphasizing on acquisition and geographical expansion to enhance their position in over-the-counter market.

Table of Contents
Product Code: 1884

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
    • 1.1.1. Initial data exploration
    • 1.1.2. Statistical model and forecast
    • 1.1.3. Industry insights and validation
    • 1.1.4. Market definition & forecast parameters
  • 1.2. Data sources
    • 1.2.1. Secondary
    • 1.2.2. Primary

Chapter 2. Executive Summary

  • 2.1. Over-the-counter (OTC) drugs industry 360 degree synopsis, 2014 - 2025
    • 2.1.1. Business trends
    • 2.1.2. Product trends
    • 2.1.3. Regional trends

Chapter 3. Over-the-counter (OTC) Drugs Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2014 - 2025
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Pharmaceutical companies switching from Rx to OTC drugs especially in the U.S
      • 3.3.1.2. Growing trend of self-medication in developing economies
      • 3.3.1.3. Significant cost savings due to OTC drug usage in Asia pacific and Latin America
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. Several concerns pertaining to incorrect diagnosis and substance abuse
  • 3.4. Growth potential analysis
    • 3.4.1. By product
  • 3.5. Regulatory landscape
    • 3.5.1. U.S.
    • 3.5.2. Europe
  • 3.6. Porter's analysis
  • 3.7. Competitive landscape, 2017
    • 3.7.1. Business overview
    • 3.7.2. Revenue analysis
    • 3.7.3. Product landscape
    • 3.7.4. Strategy dashboard
  • 3.8. PESTEL analysis

Chapter 4. Over-the-counter (OTC) Drugs Market, By Product

  • 4.1. Key segment trends
  • 4.2. Analgesics
    • 4.2.1. Market estimates and forecast, by region, 2014 - 2025
  • 4.3. Cold, cough & flu products
    • 4.3.1. Market estimates and forecast, by region, 2014 - 2025
  • 4.4. Weight loss products
    • 4.4.1. Market estimates and forecast, by region, 2014 - 2025
  • 4.5. Gastrointestinal products
    • 4.5.1. Market estimates and forecast, by region, 2014 - 2025
  • 4.6. Skin products
    • 4.6.1. Market estimates and forecast, by region, 2014 - 2025
  • 4.7. Mineral and vitamin supplements
    • 4.7.1. Market estimates and forecast, by region, 2014 - 2025
  • 4.8. Sleeping aids
    • 4.8.1. Market estimates and forecast, by region, 2014 - 2025
  • 4.9. Ophthalmic products
    • 4.9.1. Market estimates and forecast, by region, 2014 - 2025
  • 4.10. Others
    • 4.10.1. Market estimates and forecast, by region, 2014 - 2025

Chapter 5. Over-the-counter (OTC) Drugs Market, By Region

  • 5.1. Key regional trends
  • 5.2. North America
    • 5.2.1. Market estimates and forecast, by country, 2014 - 2025
    • 5.2.2. Market estimates and forecast, by product, 2014 - 2025
    • 5.2.3. U.S.
      • 5.2.3.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.2.4. Canada
      • 5.2.4.1. Market estimates and forecast, by product, 2014 - 2025
  • 5.3. Europe
    • 5.3.1. Market estimates and forecast, by country, 2014 - 2025
    • 5.3.2. Market estimates and forecast, by product, 2014 - 2025
    • 5.3.3. Germany
      • 5.3.3.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.3.4. UK
      • 5.3.4.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.3.5. France
      • 5.3.5.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.3.6. Italy
      • 5.3.6.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.3.7. Spain
      • 5.3.7.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.3.8. Russia
      • 5.3.8.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.3.9. Poland
      • 5.3.9.1. Market estimates and forecast, by product, 2014 - 2025
  • 5.4. Asia Pacific
    • 5.4.1. Market estimates and forecast, by country, 2014 - 2025
    • 5.4.2. Market estimates and forecast, by product, 2014 - 2025
    • 5.4.3. India
      • 5.4.3.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.4.4. China
      • 5.4.4.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.4.5. Japan
      • 5.4.5.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.4.6. Australia
      • 5.4.6.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.4.7. South Korea
      • 5.4.7.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.4.8. Taiwan
      • 5.4.8.1. Market estimates and forecast, by product, 2014 - 2025
  • 5.5. Latin America
    • 5.5.1. Market estimates and forecast, by country, 2014 - 2025
    • 5.5.2. Market estimates and forecast, by product, 2014 - 2025
    • 5.5.3. Mexico
      • 5.5.3.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.5.4. Brazil
      • 5.5.4.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.5.5. Argentina
      • 5.5.5.1. Market estimates and forecast, by product, 2014 - 2025
  • 5.6. Middle East and Africa
    • 5.6.1. Market estimates and forecast, by country, 2014 - 2025
    • 5.6.2. Market estimates and forecast, by product, 2014 - 2025
    • 5.6.3. South Africa
      • 5.6.3.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.6.4. Saudi Arabia
      • 5.6.4.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.6.5. Kuwait
      • 5.6.5.1. Market estimates and forecast, by product, 2014 - 2025
    • 5.6.6. Qatar
      • 5.6.6.1. Market estimates and forecast, by product, 2013 - 2024

Chapter 6. Company Profiles

  • 6.1. Bayer HealthCare
    • 6.1.1. Business overview
    • 6.1.2. Financial data
    • 6.1.3. Product landscape
    • 6.1.4. Strategic outlook
    • 6.1.5. SWOT analysis
  • 6.2. GlaxoSmithKline (GSK)
    • 6.2.1. Business overview
    • 6.2.2. Financial data
    • 6.2.3. Product landscape
    • 6.2.4. Strategic outlook
    • 6.2.5. SWOT analysis
  • 6.3. Sanofi
    • 6.3.1. Business overview
    • 6.3.2. Financial data
    • 6.3.3. Product landscape
    • 6.3.4. Strategic outlook
    • 6.3.5. SWOT analysis
  • 6.4. Johnson & Johnson
    • 6.4.1. Business overview
    • 6.4.2. Financial data
    • 6.4.3. Product landscape
    • 6.4.4. Strategic outlook
    • 6.4.5. SWOT analysis
  • 6.5. Pfizer
    • 6.5.1. Business overview
    • 6.5.2. Financial data
    • 6.5.3. Product landscape
    • 6.5.4. Strategic outlook
    • 6.5.5. SWOT analysis
  • 6.6. Sun Pharmaceutical Industries Ltd.
    • 6.6.1. Business overview
    • 6.6.2. Financial data
    • 6.6.3. Product landscape
    • 6.6.4. Strategic outlook
    • 6.6.5. SWOT analysis
  • 6.7. Alkem Laboratories Limited
    • 6.7.1. Business overview
    • 6.7.2. Financial data
    • 6.7.3. Product landscape
    • 6.7.4. Strategic outlook
    • 6.7.5. SWOT analysis
  • 6.8. Cipla, Inc.
    • 6.8.1. Business overview
    • 6.8.2. Financial data
    • 6.8.3. Product landscape
    • 6.8.4. Strategic outlook
    • 6.8.5. SWOT analysis
  • 6.9. Teva Pharmaceutical Industries Ltd.
    • 6.9.1. Business overview
    • 6.9.2. Financial data
    • 6.9.3. Product landscape
    • 6.9.4. Strategic outlook
    • 6.9.5. SWOT analysis
  • 6.10. Glenmark Pharmaceuticals Ltd.
    • 6.10.1. Business overview
    • 6.10.2. Financial data
    • 6.10.3. Product landscape
    • 6.10.4. Strategic outlook
    • 6.10.5. SWOT analysis
  • 6.11. Takeda
    • 6.11.1. Business overview
    • 6.11.2. Financial data
    • 6.11.3. Product landscape
    • 6.11.4. Strategic outlook
    • 6.11.5. SWOT analysis
  • 6.12. Innovus Pharmaceutical Inc.
    • 6.12.1. Business overview
    • 6.12.2. Financial data
    • 6.12.3. Product landscape
    • 6.12.4. Strategic outlook
    • 6.12.5. SWOT analysis
  • 6.13. Dr. Reddy's Laboratories
    • 6.13.1. Business overview
    • 6.13.2. Financial data
    • 6.13.3. Product landscape
    • 6.13.4. Strategic outlook
    • 6.13.5. SWOT analysis
  • 6.14. Reckitt Benckiser Group Plc
    • 6.14.1. Business overview
    • 6.14.2. Financial data
    • 6.14.3. Product landscape
    • 6.14.4. Strategic outlook
    • 6.14.5. SWOT analysis
  • 6.15. Piramal
    • 6.15.1. Business overview
    • 6.15.2. Financial data
    • 6.15.3. Product landscape
    • 6.15.4. Strategic outlook
    • 6.15.5. SWOT analysis

Data Tables

  • TABLE 1. Over-the-counter (OTC) drugs industry 360 degree synopsis, 2013 - 2024
  • TABLE 2. Global OTC drugs market, 2014 - 2025 (USD Billion)
  • TABLE 3. Global OTC drugs market, by product, 2014 - 2018 (USD Million)
  • TABLE 4. Global OTC drugs market, by product, 2019 - 2025 (USD Million)
  • TABLE 5. Global OTC drugs market, by region, 2014 - 2025 (USD Billion)
  • TABLE 6. Industry impact forces
  • TABLE 7. U.S. FDA prescription to over-the-counter (OTC) switch list
  • TABLE 8. Analgesics market size, by region, 2014 - 2018 (USD Billion)
  • TABLE 9. Analgesics market size, by region, 2019 - 2025 (USD Billion)
  • TABLE 10. Cold, cough and flu market size, by region, 2014 - 2018 (USD Billion)
  • TABLE 11. Cold, cough and flu market size, by region, 2019 - 2025 (USD Billion)
  • TABLE 12. Weight loss market size, by region, 2014 - 2018 (USD Billion)
  • TABLE 13. Weight loss market size, by region, 2019 - 2025 (USD Billion)
  • TABLE 14. Gastrointestinal market size, by region, 2014 - 2018 (USD Billion)
  • TABLE 15. Gastrointestinal market size, by region, 2019 - 2025 (USD Billion)
  • TABLE 16. Skin market size, by region, 2014 - 2018 (USD Billion)
  • TABLE 17. Skin market size, by region, 2019 - 2025 (USD Billion)
  • TABLE 18. Minerals and vitamins market size, by region, 2014 - 2018 (USD Billion)
  • TABLE 19. Minerals and vitamins market size, by region, 2019 - 2025 (USD Billion)
  • TABLE 20. Sleeping aids market size, by region, 2014 - 2018 (USD Billion)
  • TABLE 21. Sleeping aids market size, by region, 2019 - 2025 (USD Billion)
  • TABLE 22. Ophthalmic market size, by region, 2014 - 2018 (USD Billion)
  • TABLE 23. Ophthalmic market size, by region, 2019 - 2025 (USD Billion)
  • TABLE 24. Others market size, by region, 2014 - 2018 (USD Billion)
  • TABLE 25. Others market size, by region, 2019 - 2025 (USD Billion)
  • TABLE 26. North America OTC drugs market size, by country, 2014 - 2025 (USD Billion)
  • TABLE 27. North America OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 28. North America OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 29. U.S. OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 30. U.S. OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 31. Canada OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 32. Canada OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 33. Europe OTC drugs market size, by country, 2014 - 2025 (USD Billion)
  • TABLE 34. Europe OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 35. Europe OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 36. Germany OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 37. Germany OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 38. UK OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 39. UK OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 40. France OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 41. France OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 42. Italy OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 43. Italy OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 44. Spain OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 45. Spain OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 46. Russia OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 47. Russia OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 48. Poland OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 49. Poland OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 50. Asia Pacific OTC drugs market size, by country, 2014 - 2025 (USD Billion)
  • TABLE 51. Asia Pacific OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 52. Asia Pacific OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 53. India OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 54. India OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 55. China OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 56. China OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 57. Japan OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 58. Japan OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 59. Australia OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 60. Australia OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 61. South Korea OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 62. South Korea OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 63. Taiwan OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 64. Taiwan OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 65. Latin America OTC drugs market size, by country, 2014 - 2025 (USD Billion)
  • TABLE 66. Latin America OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 67. Latin America OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 68. Brazil OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 69. Brazil OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 70. Mexico OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 71. Mexico OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 72. Argentina OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 73. Argentina OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 74. Middle East and Africa OTC drugs market size, by country, 2014 - 2025 (USD Billion)
  • TABLE 75. Middle East and Africa market size, by product, 2014 - 2025 (USD Billion)
  • TABLE 76. South Africa OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 77. South Africa OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 78. Saudi Arabia OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 79. Saudi Arabia OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 80. Kuwait OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 81. Kuwait OTC drugs market size, by product, 2019 - 2025 (USD Million)
  • TABLE 82. Qatar OTC drugs market size, by product, 2014 - 2018 (USD Million)
  • TABLE 83. Qatar OTC drugs market size, by product, 2019 - 2025 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global over-the-counter (OTC) drugs market, 2014- 2025 (USD Million)
  • FIG. 3 Growth potential analysis, by product
  • FIG. 4 Porter's analysis
  • FIG. 5 PESTEL analysis
  • FIG. 6 Strategy dashboard
  • FIG. 7 Over-the-counter (OTC) drugs market share, by product, 2018 & 2025
  • FIG. 8 Over-the-counter (OTC) drugs market share, by region, 2018 & 2025
Back to Top